Christopher Schaber - Soligenix Chairman, CEO and Pres
SNGX Stock | USD 0.60 0.01 1.64% |
Chairman
Dr. Christopher J. Schaber, Ph.D., is Chairman of the Board, President, Chief Executive Officer of Soligenix Inc., he has over 28 years of experience in the pharmaceutical and biotechnology industry. He was our President and Chief Executive Officer and a director since August 2006. He was appointed Chairman of the Board on October 8, 2009. He also has served on the board of directors of the Biotechnology Council of New Jersey since January 2009 and the Alliance for Biosecurity since October 2014, and was a member of the corporate councils of both the National Organization for Rare Diseases and the American Society for Blood and Marrow Transplantation since October 2009 and July 2009, respectively. Prior to joining Soligenix, He served from 1998 to 2006 as Executive Vice President and Chief Operating Officer of Discovery Laboratories, Inc., where he was responsible for overall pipeline development and key areas of commercial operations, including regulatory affairs, quality control and assurance, manufacturing and distribution, preclinical and clinical research, and medical affairs, as well as coordination of commercial launch preparation activities. From 1996 to 1998, Dr. Schaber received his BA degree from Western Maryland College, his MS degree in Pharmaceutics from Temple University School of Pharmacy and his PhD degree in Pharmaceutical Sciences from the Union Graduate School. Dr. Schaber was selected to serve as a member of our Board of Directors because of his extensive experience in drug development and pharmaceutical operations, including his experience as an executive senior officer with our Company and Discovery Laboratories, Inc., and as a member of the board of directors of BioNJ because of his proven ability to raise funds and provide access to capital and because of his advanced degrees in science and business. since 2009.
Age | 58 |
Tenure | 15 years |
Address | 29 Emmons Drive, Princeton, NJ, United States, 08540 |
Phone | 609 538 8200 |
Web | https://www.soligenix.com |
Christopher Schaber Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Schaber against Soligenix stock is an integral part of due diligence when investing in Soligenix. Christopher Schaber insider activity provides valuable insight into whether Soligenix is net buyers or sellers over its current business cycle. Note, Soligenix insiders must abide by specific rules, including filing SEC forms every time they buy or sell Soligenix'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Schaber 2 days ago Acquisition by Christopher Schaber of 10770 shares of Soligenix at 0.93 subject to Rule 16b-3 | ||
Christopher Schaber over a month ago Purchase by Christopher Schaber of 7000 shares of Soligenix | ||
Christopher Schaber over three months ago Acquisition by Christopher Schaber of 150000 shares of Soligenix subject to Rule 16b-3 | ||
Christopher Schaber over a year ago Acquisition by Christopher Schaber of 60000 shares of Soligenix subject to Rule 16b-3 |
Soligenix Management Efficiency
The company has return on total asset (ROA) of (0.3997) % which means that it has lost $0.3997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (237.8376) %, meaning that it created substantial loss on money invested by shareholders. Soligenix's management efficiency ratios could be used to measure how well Soligenix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to -2.22 in 2024. Return On Assets is likely to drop to -0.66 in 2024. At this time, Soligenix's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 909.3 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 275.5 K in 2024.Similar Executives
Found 4 records | CHAIRMAN Age | ||
Gerald Deitchle | BJs Restaurants | 66 | |
Michael Weinstein | Ark Restaurants Corp | 81 | |
Daniel Meyer | Shake Shack | 66 | |
Jon Bortz | Pebblebrook Hotel Trust | 63 |
Management Performance
Return On Equity | -237.84 | ||||
Return On Asset | -0.4 |
Soligenix Leadership Team
Elected by the shareholders, the Soligenix's board of directors comprises two types of representatives: Soligenix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Soligenix. The board's role is to monitor Soligenix's management team and ensure that shareholders' interests are well served. Soligenix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Soligenix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jerome Zeldis, Independent Director | ||
Richard Straube, Senior Vice President and Chief Medical Officer | ||
Marco Brughera, Director | ||
Gregg Lapointe, Independent Director | ||
Keith Brownlie, Independent Director | ||
Karen Krumeich, CFO, Senior Vice President | ||
Richard Dunning, Ex Officer | ||
Anthony Lapointe, Independent Director | ||
Diane Parks, Director | ||
Oreola Donini, Chief Scientific Officer and Sr. VP | ||
Christopher Schaber, Chairman, CEO and Pres | ||
Joseph Warusz, Acting CFO, Vice President - Finance, Corporate Secretary | ||
Mark Pearson, Director | ||
Robert Rubin, Independent Director | ||
CGMA CPA, CFO VP | ||
MSc MD, Senior Officer |
Soligenix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Soligenix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -237.84 | ||||
Return On Asset | -0.4 | ||||
Operating Margin | (8.73) % | ||||
Current Valuation | 1.42 M | ||||
Shares Outstanding | 10.52 M | ||||
Shares Owned By Insiders | 0.10 % | ||||
Shares Owned By Institutions | 3.60 % | ||||
Number Of Shares Shorted | 67.71 K | ||||
Price To Earning | (1.67) X | ||||
Price To Book | 2.53 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Soligenix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Soligenix's short interest history, or implied volatility extrapolated from Soligenix options trading.
Currently Active Assets on Macroaxis
When determining whether Soligenix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soligenix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soligenix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soligenix Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soligenix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Soligenix Stock please use our How to Invest in Soligenix guide.Note that the Soligenix information on this page should be used as a complementary analysis to other Soligenix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Soligenix Stock analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Soligenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soligenix. If investors know Soligenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soligenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Revenue Per Share 0.108 | Quarterly Revenue Growth (0.33) | Return On Assets (0.40) | Return On Equity (237.84) |
The market value of Soligenix is measured differently than its book value, which is the value of Soligenix that is recorded on the company's balance sheet. Investors also form their own opinion of Soligenix's value that differs from its market value or its book value, called intrinsic value, which is Soligenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soligenix's market value can be influenced by many factors that don't directly affect Soligenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soligenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Soligenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soligenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.